Table 2.
Lipid profile of normal T-score, osteopenic, and osteoporotic postmenopausal Sudanese women.
| Normal T-score n = 80, 26.6% | Osteopenia n = 110, 37.7% |
Osteoporosis n = 110, 37.7% |
Total n = 300 |
P value∗ | |
|---|---|---|---|---|---|
| Total cholesterol (mg/dL) | |||||
| Mean (SD)# | 173.6 (38.1) | 174.6 (44.3) | 181.9 (41.3) | 177.0 (41.6) | |
| Median (S.E.M) | 176.0 (4.2) | 170.5 (4.2) | 182.5 (3.9) | 177.0 (2.4) | 0.124∗ |
| Q1–Q3 | 146.7–197.5 | 141.0–194.2 | 159.7–200.0 | 149.2–199.0 | |
|
| |||||
| TC classification | |||||
| Normal <200.0 | 61.0 (76.3)‡ | 85.0 (77.3) | 81.0 (73.6) | 227.0 (75.7) | 0.712a |
| Borderline 200.0–239.0 | 16.0 (20.0) | 17.0 (15.5) | 20.0 (18.2) | 53.0 (17.7) | |
| High ≥240.0 | 3.0 (3.8) | 8.0 (7.3) | 9.0 (8.2) | 20.0 (6.7) | |
|
| |||||
| Triglycerides (mg/dL) | |||||
| Mean (SD)# | 125.7 (39.7) | 120.0 (51.4) | 123.3 (49.8) | 122.7 (47.9) | |
| Median (SEM) † | 119.0 (4.4) | 109.0 (4.9) | 108.5 (4.7) | 111.0(2.7) | 0.293∗ |
|
| |||||
| Q1–Q3 | 101.2–150.7 | 89.0–141.7 | 86.5–154.2 | 90.0–150.0 | |
|
| |||||
| TG classification | |||||
| Normal <150.0 | 59.0 (73.8)‡ | 88.0 (80.0) | 76.0 (69.1) | 223.0 (74.3) | 0.307a |
| Borderline high 150.0–199.0 | 16.0 (20.0) | 15.0 (13.6) | 21.0 (19.1) | 52.0 (17.3) | |
| ≥200.0 | 5.0 (6.3) | 7.0 (6.4) | 13.0 (11.8) | 25.0 (8.3) | |
|
| |||||
| LDL-C (mg/dL) | |||||
| Mean (SD)# mg/dL | 93.9 (27.0) | 92.5 (32.8) | 99.5 (32.1) | 95.4 (31.1) | |
| Median (SEM) † | 90.5 (3.0) | 88.3 (3.1) | 99.0 (3.0) | 93.0 (1.8) | 0.169∗ |
| Q1–Q3 | 75.7–112.7 | 71.0–110.0 | 74.7–118.5 | 74.0–115.0 | |
|
| |||||
| LDL-C classification | |||||
| Normal <130.0 | 70.0 (88.6)‡ | 96.0 (87.3) | 92.0 (83.6) | 258.0 (86.3) | 0.596a |
| Borderline high 130.0–159.0 | 8.0 (10.1) | 9.0 (8.2) | 14.0 (12.7) | 31.0 (10.4) | |
| High 160.0–189.0 | 1.0 (1.3) | 5.0 (4.5) | 4.0 (3.6) | 10.0 (3.3) | |
|
| |||||
| HDL-C (mg/dL) | |||||
| Mean (SD)# mg/dL | 50.2 (15.5) | 47.8 (15.7) | 48.9 (15.0) | 48.8 (15.3) | |
| Median (S.E.M)† | 47.0 (1.7) | 45.5 (1.4) | 47.0 (1.4) | 46.5 (0.8) | 0.470∗ |
| Q1–Q3 | 39.0–61.0 | 35.0–57.5 | 38.0–58.0 | 37.0–58.0 | |
|
| |||||
| HDL-C classification | |||||
| Low ≤40.0 | 24.0 (30.0) | 44.0 (40.0) | 36.0 (32.7) | 104.0 (34.7) | 0.510a |
| Borderline low 59.0–41.0 | 34.0 (42.5) | 40.0 (36.4) | 50.0 (45.5) | 124.0 (41.3) | |
| Optimal ≥60.0 | 22.0 (27.5)‡ | 26.0 (23.6) | 24.0 (21.8) | 72.0 (24.0) | |
|
| |||||
| Atherogenic index of plasma | |||||
| Mean (SD) | 0.037 (0.1) | 0.033 (0.1) | 0.026 (0.2) | 0.032 (0.1) | 0.928† |
| Median (S.E.M)† | 0.040 (0.01) | 0.010 (0.01) | −0.002 (0.02) | 0.017 (0.01) | |
| Q1–Q3 | −0.087–0.135 | −0.094–0.139 | −0.130–0.159 | −0.111–0.142 | |
|
| |||||
| AIP classification | |||||
| Low risk <0.1 | 52.0 (65.0)‡ | 78.0 (70.9) | 70.0 (63.6) | 200.0 (66.7) | 0.137a |
| Medium risk 0.1–0.24 | 20.0 (25.0) | 13.0 (11.8) | 22.0 (20.0) | 55.0 (18.3) | |
| High risk >0.24 | 8.0 (10.0) | 19.0 (17.3) | 18.0 (16.4) | 45.0 (15.0) | |
#Mean, geometric mean; SD, standard deviation; †median; S.E.M, standard error of mean; Q1–Q3 interquartile ranges; ‡values are numbers and percentages; †P value was obtained using ANOVA test with post hoc multiple comparison analysis to compare between means; ∗P value was obtained using the Kruskal–Wallis test to compare between medians; aP value was obtained using the chi-square test to compare between frequencies.